Robert Freedland Profile Picture Individual Investor

Robert Freedland

Ophthalmologist,Hospital and Health Care

  • EducationPrinceton University; University of California, Davis
  • QualificationsAB, MD
  • Investment ExperienceManaging own investments for 42 years, active stock blogger/podcaster for 7 years


My portfolio invests in healthcare-related stocks. It attemps to identify companies with reasonable valuations and good prospects for growth including ones that offer possible dividends to stockholders. These companies will range from drug, device, retail sales, electronic medical record, prescription services, and HMO/hospital companies. While emphasizing mid cap stocks, large cap and smaller capitalization companies may be included as well as emerging medical treatments/technologies.

Risk score

Risk Score 3

Best 30 days


Worst 30 days


  • -7.5%
    30 day
  • -13.6%
    90 day
  • 2.1%
    365 day
    October 06, 2010
Monthly vs S&P500
Robert Freedland - Healthcare Monthly vs S&P500
5.8% 12 months
  • $20,000 investment min
  • 1% fee


  • Consumer, Non-cyclical
  • Industrial
  • Consumer, Cyclical

Top 5 securities View all


Portfolio commentary

  1. 7 ways to navigate the investment maze

    15 September 2015

    Look for momentum, stay humble, spread risks and limit losses.

  2. Keeping balance in a scary stock market 21 August 2015
  3. An investor’s guide to March Madness 20 March 2015
  4. Beware of the deflation whirlpool 18 March 2015
  5. Why Apple is an excellent deflation hedge 9 February 2015

show more

Performance detail

  • Manager (net of fees)
  • S&P 500 Healthcare


Covestor inception October 06, 2010

as of October 08, 2015 Manager (net of fees) S&P 500 Healthcare S&P 500
Past 30 days -7.5% -3.2% 2.4%
Past 90 days -13.6% -9.1% -2.5%
Past 365 days 2.1% 6.8% 4.4%
Since Covestor inception (Annualized) 15.4% 19.5% 14.0%
2015 (YTD) -4.1% 0.6% -0.6%
2014 23.4% 25.3% 13.7%
2013 49.8% 41.5% 32.4%
2012 18.8% 17.9% 16.0%
2011 -7.4% 12.7% 2.1%

Risk metrics

Last 365 days

as of October 08, 2015 Manager (net of fees) S&P 500 Healthcare S&P 500
Best 30 days 11.2% 12.2% 9.7%
Worst 30 days -10.7% -10.9% -10.0%
Volatility 16.5% 18.0% 15.3%
Sharpe Ratio 0.13 0.38 0.29
Sortino Ratio 0.17 0.52 0.40
Maximum Drawdown -16.1% -16.4% -12.0%
Value-at-risk (95%, 1 week) -3.8% -4.2% -3.5%
vs. S&P 500 Healthcare vs. S&P 500
Information Ratio - 0.72 - 0.24
Alpha -3.5% -1.4%
Beta 0.86 0.90
R-Squared 0.87 0.69
  • $20,000 investment min
  • 1% fee

Latest transactions View all

Average trades per month 9.3
Executed Symbol Security Type Price
10/08/15 LLY Eli Lilly & Co Sell $82.08
10/07/15 BIIB Biogen Inc Buy $281.03
10/07/15 AMGN Amgen Inc Buy $147.37
10/07/15 INGN Inogen Inc Sell $45.22
10/07/15 EW Edwards Lifesciences Corp Sell $144.07
10/05/15 TMO Thermo Fisher Scientific Inc Buy $126.52
10/05/15 CVS CVS Health Corp Buy $101.66
10/05/15 SLP Simulations Plus Inc Sell $9.53

Important Information

  1. Past performance is no guarantee of future results.
  2. Performance of the Portfolio Manager's account is calculated by Covestor on a daily time-weighted basis, including cash, dividends and earnings distributions and broker commissions. Manager returns include trades and positions that fail Covestor's trading rules, as a result, actual client returns will differ. Covestor advisory fees are simulated and applied retro-actively to present the portfolio return "net-of-fees".
  3. Average client returns are calculated by Covestor and are composed of the asset-weighted average returns of all active client investments (some of which may contain investment restrictions) to the underlying portfolio. These daily average returns are then linked together for the timeframe presented. These returns include cash, dividends, earnings distributions, brokerage commissions and Covestor advisory fees.
  4. All graph data is as of the end of day for the referenced period, unless otherwise specified. The investment minimum is the minimum investment required to follow a particular portfolio. The minimum amount is determined by Covestor, based on the characteristics of the underlying portfolio. It should not be considered as specific investment advice for your investment situation.
  5. The performance charts are provided for informational purposes only, and should not be used as the basis for making an investment decision. Variables such as corporate actions or foreign exchange may affect daily performance displays. We rely on mathematical formulas, computer programs, and pricing information from third-party vendors to provide these returns. Neither Covestor nor any of its data or content providers shall be liable for any errors in this information or any actions taken by you in reliance upon this information.
  6. Benchmark returns have been calculated by Covestor using a time-weighted calculation of daily index valuations. Benchmarks presented are total return and therefore inclusive of cash, dividends and earnings distributions but not transaction costs. More
  7. Leverage indicates the level of margin utilized and is calculated by dividing gross exposure by portfolio net liquidation value.
  8. All Portfolio Manager information including personal data, profiles, strategies, monthly investment reports, and historical results outside of Covestor has been provided by the Portfolio Manager. Covestor makes no representation or warranty of its accuracy, completeness or relevance and it does not represent the opinions of Covestor. Transaction history is available upon request. Portfolio classifications are provided by Covestor, and are intended to serve as a general guide.
  9. Not all transactions listed will appear in your account due to Covestor's trading rules and individual client constraints. Eligibility of these securities is monitored periodically, and may change over time. Actual client investment holdings may vary.
  10. Index returns do not reflect any management fees, transaction costs or expenses. Individuals cannot invest directly in an Index.